Actively Recruiting

Age: 18Years - 99Years
MALE
NCT07290270

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Led by Novartis Pharmaceuticals · Updated on 2026-03-30

170

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This non-interventional, observational, multicenter, prospective cohort study is designed to investigate the treatment patterns of mPC patients treated with lutetium (177Lu) vipivotide tetraxetan, as well as their clinical outcomes, real-world characteristics, and quality of life during the treatment period and up to one year after treatment completion.

CONDITIONS

Official Title

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Who Can Participate

Age: 18Years - 99Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult male patients diagnosed with metastatic castration-resistant prostate cancer (mCRPC) or metastatic hormone-sensitive prostate cancer (mHSPC)
  • Patients starting lutetium (177Lu) vipivotide tetraxetan treatment as decided by their treating physician following local label
  • Enrollment allowed before start of treatment cycle 1 or within 2 weeks after cycle 1
  • Written informed consent must be obtained before any data collection
  • Adequate organ function as defined by Society of Nuclear Medicine and Molecular Imaging (SNMMI) consensus
Not Eligible

You will not qualify if you...

  • Participation in any other investigational trial during the study period
  • Participation in another Novartis-sponsored non-interventional study with lutetium (177Lu) vipivotide tetraxetan during the study period
  • Other protocol-defined exclusion criteria may apply

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Novartis Investigative Site

Shanghai, Shanghai Municipality, China, China

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here